We are pleased to present below all posts archived in 'January, 2014'. If you still can't find what you are looking for, try using the search box.
OXFORD, UK and MARLBOROUGH, MA, January. 31, 2014 (GLOBE NEWSWIRE) – Oxford Immunotec Global PLC (Nasdaq: OXFD) announced today that its CEO, Dr. Peter Wrighton-Smith has been named the UK BioIndustry Association Entrepreneur of the Year.
Read the rest of entry »
Cardiff, UK – 21st January 2014 – EKF Diagnostics, the global in vitro diagnostics business, announces a major breakthrough for its PointMan™ DNA enrichment technology for potential use in future cancer testing and treatment.
A review of the government’s Strategy for UK Life Sciences has found that eight out of the 13 initiatives reviewed have made notable progress towards the actions and commitments set out in the original strategy, but there is still much more work to do to meet the strategy’s original objectives.
Building on the wide range of products available from DiaSorin for stool diagnostics, with each DiaSorin LIAISON® Ixt/Arrow™ instrument purchased during February 2014, DiaSorin is providing 2000€ worth of LIAISON® Ixt/Arrow™ Stool DNA extraction kits completely free of charge. This offer provides an ideal opportunity to experience how LIAISON® Ixt/Arrow™ magnetic bead technology overcomes the difficulties of extracting highly purified DNA from stool samples.
Cardiff, UK – 9th January 2014 – EKF Diagnostics, a global diagnostics company, is pleased to announce that its Quo-Lab HbA1c point-of-care analyzer has successfully achieved International Federation of Clinical Chemistry and Laboratory Medicine (IFCC) certification.
OXFORD, UK and MARLBOROUGH, MA, January. 08, 2014 (GLOBE NEWSWIRE)
Oxford Immunotec Global PLC (Nasdaq: OXFD) today announced that Peter Wrighton-Smith Ph.D., Chief
Executive Officer, and Rick Altieri, Chief Financial Officer, will present at the 32nd Annual J.P. Morgan
Healthcare Conference at the Westin St. Francis Hotel in San Francisco, California on Thursday, January 16, 2014 at 12:30 pm PT.
A live webcast of the presentation will be available online from the investor relations page of the
Company’s corporate website at www.oxfordimmunotec.com.
Cardiff, UK – 7th January 2014 – EKF Diagnostics, the global in vitro diagnostics business, will be exhibiting two newly introduced point-of-care (POC) testing analyzers for rapid assessment of diabetes and related conditions. The Quo-Lab glycated haemoglobin (HbA1c) analyzer and STAT-Site M ß-HB will both be demonstrated on the Welsh Assembly Government Stand Z1D30 in Zabeel Hall 1, Arab Health, Dubai International Convention & Exhibition Centre, 27 - 30 January 2014.
Who are the BIVDA Members
Member Press Releases
Point of Care Directory
News, Policy and Media
BIVDA Press Releases